Comparing effect of two ayurvedic modalities, Siravedha and Jaloukaavacharan in Diabetes related Neuropathies.

Clinical Efficacy of Jalaukavacharana (Leech Therapy) and Siravedha (Blood Letting) in Diabetic Peripheral Neuropathy- An Open Labelled Randomised Comparative Clinical Trial. - DPN

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/111544

Enrollment

Registered

2026-06-01

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G63- Polyneuropathy in diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having the symptoms of Diabetic Peripheral Neuropathy i.e. Ruja that is pain. Daha that is burning sensation. Supti that is numbness. Harsha that is tingling sensation. Insensitivity to vibration and hot or cold in feet. Patients having blood sugar level FBS less than 200 mg/dl & PPBS less than 400 mg/dl.

Exclusion criteria

Exclusion criteria: 1. Patients having any other associated clinical conditions influencing peripheral nerve function like chronic kidney disease. 2. Age below 30 years and above 75 years. 3. Blood sugar level FBS more than 200 mg/dl & PPBS more than 400 mg/dl. 4. Pregnancy and Lactating women. 5. Severe Anaemia Hb less than 6g/dl. 6. Haemolytic disorders and patient unfit for Jalaukavacharana that is Leech Therapy and Siravedha that is Blood Letting. 7. Blood borne infections.

Design outcomes

Primary

Measure	Time frame
1. Reduction in tingling sensation. 2. Reduction in pain and numbness.Timepoint: 4 weeks	—

Secondary

Measure	Time frame
Absence of recurrence in follow up period.Timepoint: 60 days	—

Countries

India

Contacts

Public ContactDr T S Dudhamal

Institute of Teaching and Research Jamnagar

drtsdudhamal@gmail.com8849298620

Outcome results